middle.news
CLINUVEL Unveils Promising Vitiligo Repigmentation Cases with SCENESSE®
8:35am on Friday 19th of September, 2025 AEST
•
Healthcare
Read Story
CLINUVEL Unveils Promising Vitiligo Repigmentation Cases with SCENESSE®
8:35am on Friday 19th of September, 2025 AEST
Key Points
Three vitiligo patients showed notable repigmentation after SCENESSE® treatment
Treatment combined seven SCENESSE® implants with up to 40 NB-UVB phototherapy sessions
Patients reported satisfaction and no unexpected safety issues
Repigmentation effects remained stable 14 weeks post-treatment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE